false 0001739174 0001739174 2026-09-01 2026-09-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): September 1, 2026

 

BIOMX INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-38762   82-3364020
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (I.R.S. Employer
Identification No.)

 

850 New Burton Road, Suite 201, Dover, Delaware 19904

(Address of principal executive offices, including zip code)

 

(972) 52-437-4900

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.0001 par value per share   PHGE   NYSE American

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 8.01 Other Events.

 

On September 1, 2026, BiomX Inc. (the “Company”) announced that it will change its corporate name to Tessera Defense and Homeland Security Inc., effective at 12:01 a.m., Eastern Time, on September 11, 2026 (the “Name Change”). On August 31, 2026, the Company’s Board of Directors approved the Name Change and an amendment to the Company’s Amended and Restated Certificate of Incorporation to effect it. Pursuant to Section 242(d)(1) of the Delaware General Corporation Law, no stockholder approval is required. The Company expects to file a certificate of amendment with the Secretary of State of the State of Delaware, to become effective at the time stated above.

 

In connection with the Name Change, the Company’s common stock will begin trading on the NYSE American under the new ticker symbol “HLSQ” at the market open on September 11, 2026. The common stock will continue to trade under the symbol “PHGE” until that time. The Company’s common stock will continue to be identified by CUSIP number 09090D 608, which will be assigned upon effectiveness of the Company’s previously announced one-for-ten reverse stock split on September 9, 2026; CUSIP Global Services has confirmed that the CUSIP number will not change as a result of the Name Change.

 

The Name Change does not affect the rights of the Company’s stockholders. No action is required by stockholders, and no exchange of stock certificates or book-entry positions is required. The Name Change and the reverse stock split are separate corporate actions.

 

The Company will report the filing of the certificate of amendment under Item 5.03 of Form 8-K. A copy of the press release announcing the Name Change is attached as Exhibit 99.1 to this Current Report and is incorporated herein by reference.

 

Forward-Looking Statements. This Current Report contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including statements regarding the anticipated timing and effects of the name change, the ticker symbol change and the reverse stock split. These statements are based on the Company’s current expectations and are subject to risks and uncertainties that could cause actual results to differ materially, including the timing of the filing and effectiveness of the certificate of amendment and the processing of the corporate actions by the NYSE American and DTC, as well as the risks described in the Company’s filings with the Securities and Exchange Commission, including under “Risk Factors” in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, as amended, and the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2026. The Company undertakes no obligation to update any forward-looking statement except as required by law.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

99.1 Press Release of BiomX Inc., dated September 1, 2026
   
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

BIOMX INC.  
     
Date: September 1, 2026  
     
By: /s/ Michael Oster  
Name:  Michael Oster  
Title: Chief Executive Officer  

 

2

 

 

Exhibit 99.1

  

BiomX Inc. to Become Tessera Defense and Homeland Security Inc.

 

Name change effective September 11, 2026; common stock to trade on the NYSE American under the new symbol “HLSQ”

 

NETANYA, Israel, September 1, 2026 – BiomX Inc. (NYSE American: PHGE) (the “Company”) today announced that it will change its corporate name to Tessera Defense and Homeland Security Inc., effective at 12:01 a.m., Eastern Time, on September 11, 2026. The Company’s common stock will trade on the NYSE American under the new ticker symbol “HLSQ.”

 

The new name completes the Company’s transformation into a defense and homeland security technology group, built through the acquisitions and investments it has made over the past year.

 

A tessera is a single tile in a mosaic. Alone it is a fragment; set alongside others, it becomes part of a complete picture. The name describes how the Company is assembled: individual technology companies, each substantial in its own right, brought together into one architecture for prediction, detection, analysis and response.

 

The effective date was chosen deliberately. September 11 is the date that changed how the world understands security, and the day that gave the term homeland security its modern meaning. In adopting the name on that date, the Company honors the memory of those who were lost in 2001 and the first responders who went toward the danger, and dedicates itself to the work their loss demanded: seeing threats early, understanding them quickly, and helping those who must act on them.

 

“We did not choose this date lightly, and we do not take it lightly,” said Michael Oster, Chief Executive Officer of BiomX. “Twenty-five years ago, the failure was not one of courage. It was a failure to connect what was already known. Everything we are building is aimed at that gap: technologies that predict, detect, make sense of what they detect, and recommend a response. Tessera is the right name for that work, because no single piece of it matters on its own. What matters is the picture they make together.”

 

The Company’s portfolio today includes Dr. Frucht Systems Ltd., which develops threat detection technology; Zorro Net Ltd., which provides AI-powered prediction, analysis, validation, coordination and response recommendation or initiation, and whose systems are deployed with defense and critical infrastructure customers in Israel, including under a framework agreement with Israel Railways; and a minority interest in, and an option to acquire, M.E.A. Testing Systems Ltd. (Motomea), which specializes in electric motor testing and validation for unmanned and autonomous systems.

 

What the Name Change Means for Stockholders

 

The name change does not affect the rights of the Company’s stockholders. No action is required by stockholders, and no exchange of book-entry positions or stock certificates is necessary. The Company’s common stock will be identified by CUSIP number 09090D 608. The Company’s common stock will continue to trade under the symbol “PHGE” until the effective time of the name change.

 

As previously announced on August 28, 2026, the Company will effect a one-for-ten reverse stock split of its common stock, which is expected to become effective at 12:01 a.m., Eastern Time, on September 9, 2026, with the common stock beginning to trade on a split-adjusted basis when the market opens on that date. The reverse stock split and the name change are separate corporate actions.

 

About the Company

 

BiomX Inc., to be renamed Tessera Defense and Homeland Security Inc., is a technology group focused on defense and homeland security. Through its subsidiaries and investments, the Company develops and deploys threat detection, AI-powered analysis and related technologies for defense, security and critical infrastructure customers. The Company’s common stock is listed on the NYSE American.

 

Forward-Looking Statements

 

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the timing and effectiveness of the name change, the change of the Company’s ticker symbol, the reverse stock split, and the Company’s strategy and portfolio. Forward-looking statements are based on management’s current expectations and are subject to risks and uncertainties, including the risk that the name change or the reverse stock split does not become effective when anticipated, and those risks described in the Company’s filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K and its Quarterly Report on Form 10-Q for the quarter ended June 30, 2026. Actual results may differ materially from those expressed or implied. The Company undertakes no obligation to update any forward-looking statement, except as required by law.

 

Media Contact: Yair Ohayon, Yairo@biomx.com